What We're Reading: Page 27
Industry reads hand-picked by our editors
Mar 24, 2025
Mar 21, 2025
-
Regulatory Focus
Some FDA staff considering quitting due to Trump’s RTO policy
-
Reuters
Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
-
The New York Times
A.I. Saved His Life by Discovering New Uses for Old Drugs
-
Fierce Biotech
‘Not a cost-cutting exercise’: Novo Nordisk reshapes R&D setup
Mar 20, 2025
Mar 19, 2025
-
The Wall Street Journal
Trump Administration Weighing Major Cuts to Funding for Domestic HIV Prevention
-
Bloomberg
Pfizer Looks to Exit Haleon With Final Stake Sale
-
Fierce Pharma
Novartis to lay off 427 staffers amid marketing model rework
Mar 18, 2025
-
AP News
FDA staff return to crowded offices, broken equipment and missing chairs
-
Stat
NIH cancels funding for landmark diabetes study at a time of focus on chronic disease
-
The Wall Street Journal
How Employers Are Getting Prescription Drugs at a Fraction of the Cost
-
Fast Company
The most innovative biotech companies of 2025
Mar 17, 2025
Mar 14, 2025
-
The Boston Globe
Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.
-
The Wall Street Journal
Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
-
Financial Times
Novo Nordisk foundation’s obesity head works as paid adviser to chocolate maker Ferrero
Previous
